Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

 1,644.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 2,354.00
  • 52 Week Low: 1,630.00
  • Currency: UK Pounds
  • Shares Issued: 66.03m
  • Volume: 0
  • Market Cap: £1,085.61m
  • RiskGrade: 128
  • Beta: 1.51

Financial Analysis

Select chart: EPS | Dividend | Revenue

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-20 551.40 46.30 77.30p 45.7 7.6 +6% 29.10p 0.8%
30-Jun-21 574.30 55.80 100.90p 49.2 1.6 +30% 32.00p 0.6%
30-Jun-22 593.40 48.40 82.70p 30.3 n/a -18% 32.00p 1.3%
30-Jun-23 689.70 39.40 84.80p 25.5 12.8 +2% 32.00p 1.5%
30-Jun-24 668.80 5.50 65.50p 25.2 n/a -23% 32.00p 1.9%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-25 667.65 70.96 71.52p 23.0 2.5 +9% 32.97p 0.0%
30-Jun-26 703.94 83.82 86.13p 19.1 0.9 +20% 39.05p 0.0%
30-Jun-27 733.68 94.35 105.85p 15.5 0.7 +23% 37.13p 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 45.69 25.19 35.18 0.71

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Genus Market Data

Currency UK Pounds
Share Price 1,644.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 2,354.00
52 Week Low 1,630.00
Volume 0
Shares Issued 66.03m
Market Cap £1,085.61m
Beta 1.51
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
82.13% below the market average82.13% below the market average82.13% below the market average82.13% below the market average82.13% below the market average
84% below the sector average84% below the sector average84% below the sector average84% below the sector average84% below the sector average
Price Trend Not Available
Income
77.54% below the market average77.54% below the market average77.54% below the market average77.54% below the market average77.54% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
95.74% below the market average95.74% below the market average95.74% below the market average95.74% below the market average95.74% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Final Interim
Ex-Div 07-Nov-24 29-Feb-24
Paid 06-Dec-24 28-Mar-24
Amount 21.70p 10.30p

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

Genus Key Personnel

CFO Alison Henriksen
CEO Jorgen Kokke

Top of Page